ArticleFrontiers in immunology2026

Model-informed safety management of tocilizumab for pediatric sJIA: a PBPK approach for dose-escalation and vaccination timing.

Yujie Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.